Over the last 12 months, Disc Medicine insiders reported no purchases and 9 sales totaling $8.0M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Khara RahulChief Legal Officer · O | ▼ Sale | 5,000 | $80 | $400K | -8.7% | plan |
| Jul 13, 2026 | Quisel John DChief Executive Officer · O·D | ▼ Sale | 33,000 | $74.96 | $2.5M | -12.7% | plan · 3 tranches |
| Jul 7, 2026 | Yu Jonathan Yen-WenChief Operating Officer · O | ▼ Sale | 100 | $82.5 | $8K | -0.2% | plan |
| Jun 29, 2026 | Khara RahulChief Legal Officer · O | ▼ Sale | 2,500 | $75 | $188K | -4.6% | plan · 2 tranches |
| Jun 26, 2026 | Yu Jonathan Yen-WenChief Operating Officer · O | ▼ Sale | 300 | $72.5 | $22K | -0.5% | plan |
| Jun 22, 2026 | Yu Jonathan Yen-WenChief Operating Officer · O | ▼ Sale | 9,700 | $72.66 | $705K | -15.2% | plan |
| Jun 18, 2026 | Khara RahulChief Legal Officer · O | ▼ Sale | 7,500 | $70.22 | $527K | -12.6% | plan · 3 tranches |
| Jun 18, 2026 | Quisel John DChief Executive Officer · O·D | ▼ Sale | 34,000 | $70.21 | $2.4M | -13.1% | plan · 3 tranches |
| Jun 16, 2026 | Yu Jonathan Yen-WenChief Operating Officer · O | ▼ Sale | 18,612 | $69.19 | $1.3M | -25.5% | plan · 2 tranches |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IRON feed.